# EDGAR Filing Document

**Accession Number:** 0001627223
**File Stem:** 0000950170-23-009307
**Filing Date:** 2023-3
**Character Count:** 13356
**Document Hash:** 7e8dbfed4fa6c86308e033e4a4dbcaf8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-009307.hdr.sgml**: 20230323

**ACCESSION NUMBER**: 0000950170-23-009307

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230322

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230323

**DATE AS OF CHANGE**: 20230323

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chemours Co
- **CENTRAL INDEX KEY:** 0001627223
- **STANDARD INDUSTRIAL CLASSIFICATION:** CHEMICALS & ALLIED PRODUCTS [2800]
- **IRS NUMBER:** 464845564
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36794
- **FILM NUMBER:** 23754406

**BUSINESS ADDRESS:**
- **STREET 1:** 1007 MARKET STREET
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801
- **BUSINESS PHONE:** 302 773 1000

**MAIL ADDRESS:**
- **STREET 1:** 1007 MARKET STREET
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Chemours Company, LLC
- **DATE OF NAME CHANGE:** 20141205

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM** 8-K

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF**

**THE SECURITIES EXCHANGE ACT OF 1934**

March 22, 2023

Date of Report (Date of Earliest Event Reported)

![img171759567_0.jpg](img171759567_0.jpg)

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

---

| | | |
|:---|:---|:---|
| Delaware | 001-36794 | 46-4845564 |
| (State or Other Jurisdiction | (Commission | (I.R.S. Employer |
| Of Incorporation) | File Number) | Identification No.) |

---

1007 Market Street

Wilmington**,** Delaware 19801

(Address of principal executive offices)

Registrant's telephone number, including area code: (302) 773-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of Each Class** | **Name of Exchange on Which Registered** |
| Common Stock ($0.01 par value)<br> CC | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On March 23, 2023, the Chemours Company (the "Company") issued a press release announcing that Denise M. Dignam, who serves as the Company's President of Advanced Performance Materials, will become President, Titanium Technologies and Chemical Solutions, effective April 1, 2023. In addition, Gerardo Familiar Calderon, the Company's current Hydrogen Venture Leader, will become President, Advanced Performance Materials, effective April 1, 2023.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99.1 [<u>Press Release of the Company, dated as of March 23, 2023.</u>](cc-ex99_1.htm)

104 Cover Page Interactive Data File (formatted as Inline XBRL).

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| THE CHEMOURS COMPANY | THE CHEMOURS COMPANY |
| By: | /s/ Sameer Ralhan |
|  | Sameer Ralhan |
|  | Senior Vice President, Chief Financial Officer |
| Date: | March 23, 2023 |

---

------

## Ex-99

![img15408389_0.jpg](img15408389_0.jpg)

**EXHIBIT 99.1**

**Chemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance Materials**

Business strategies are unchanged as the company promotes top executives

**Wilmington, Del.**, March 23, 2023 – The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announces the appointment of Denise Dignam as President, Chemours Titanium Technologies and Chemical Solutions, effective April 1, 2023. Chemours will promote Gerardo Familiar to succeed Ms. Dignam as President, Chemours Advanced Performance Materials.

"Chemours is fortunate to have tremendous internal talent from which to draw in order to fill these key leadership positions," said Mark Newman, Chemours President and Chief Executive Officer. "Both Denise and Gerardo are proven leaders who have helped to drive strong business performance and embrace our passion for producing critical chemistries that are innovative, responsibly manufactured, and play an essential role in a more sustainable economy."

Denise Dignam brings more than 30 years of chemical industry experience to her new role leading Chemours' largest business segment and Chemical Solutions business. Her expertise spans commercialization, sales, marketing, strategy, supply chain, and operations. She was named to lead the Advanced Performance Materials (APM) segment in 2021 and under her leadership, the segment achieved record Net Sales, Adjusted EBITDA, and Adjusted EBITDA Margin. During her tenure, APM has accelerated growth initiatives in clean energy and advanced electronics, announced strategic partnerships and initiatives in North America and Europe, and reshaped the product portfolio from advanced materials to performance solutions to drive long term growth.

Gerardo Familiar has more than two decades of experience in the chemicals sector. He is currently general manager for the Chemours hydrogen venture where he has been central to accelerating Chemours' growth initiatives in clean energy and hydrogen solutions. Prior to that, he led Global Strategy, Marketing, and Regulatory Affairs for Thermal & Specialized Solutions (TSS). In his time with Chemours, Mr. Familiar was also Investor Relations director, and served simultaneously as president of Chemours Mexico and Latin Americas business director for both the APM and TSS segments. He was previously global business director for the Teflon™ business, held several sales and marketing positions within the fluorinated chemistries segments. And he spent almost ten years as a consultant focused on business strategy, process improvement and value-based management.

Mr. Newman added, "As I reflect on the strength of our three businesses and the depth and diversity of our leadership team, I am excited about Chemours' ability to continue delivering significant value to our stakeholders in the coming years."

**About The Chemours Company**

The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products are sold under prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The company has approximately 6,600 employees and 29 manufacturing sites serving approximately 2,900 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit <u>chemours.com</u> or follow us on Twitter <u>@Chemours</u> or <u>LinkedIn</u>.

------

![img15408389_0.jpg](img15408389_0.jpg)

**EXHIBIT 99.1**

**Forward-Looking Statements** <br> This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and interruptions in consumer and commercial activity globally. Matters outside our control, including general economic conditions, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2022. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

------

![img15408389_0.jpg](img15408389_0.jpg)

**EXHIBIT 99.1**

**INVESTORS** <br> Jonathan Lock <br>VP, Corporate Development and Investor Relations<br>+1.302.773.2263**** <br> investor@chemours.com

Kurt Bonner<br>Manager, Investor Relations<br>+1.302.773.0026<br>investor@chemours.com****

<br> **NEWS MEDIA** <br> Thom Sueta

Director, Corporate Communications

+1.302.773.3903****<br> media@chemours.com

------